» Articles » PMID: 14988020

Activation of the WT1 Tumor Suppressor Gene Promoter by Pea3

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2004 Feb 28
PMID 14988020
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Gene array profiling of RNA from cells engineered to express a dominant-negative version of the ETS family member transcription factor Pea3 (polyomavirus enhancer activator 3) identified WT1 as a candidate downstream gene. Given the co-expression of WT1 and Pea3 in developing kidney and breast tissue undergoing mesenchymal to epithelial transitions, we further characterized this potential gene hierarchy. Analysis of the human WT1 promoter revealed several potential binding sites for Pea3. Pea3 transactivated the WT1 promoter in transient transfection assays and bound to specific sites within the WT1 promoter in vitro. Our results position Pea3 upstream of WT1 and define a gene hierarchy important for mesenchymal-epithelial transitions.

Citing Articles

Identification and characterization of novel ETV4 splice variants in prostate cancer.

Cosi I, Moccia A, Pescucci C, Munagala U, Di Giorgio S, Sineo I Sci Rep. 2023; 13(1):5267.

PMID: 37002241 PMC: 10066307. DOI: 10.1038/s41598-023-29484-1.


ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.

Cosi I, Pellecchia A, De Lorenzo E, Torre E, Sica M, Nesi G J Hematol Oncol. 2020; 13(1):112.

PMID: 32791988 PMC: 7427297. DOI: 10.1186/s13045-020-00943-w.


HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.

Li H, Hou S, Hao T, Azam S, Liu C, Shi L RNA Biol. 2015; 12(12):1364-71.

PMID: 26512748 PMC: 4829285. DOI: 10.1080/15476286.2015.1102831.


Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities.

Tatsumi N, Hojo N, Yamada O, Ogawa M, Katsura Y, Kawata S Oncogene. 2015; 35(8):1003-14.

PMID: 25961914 DOI: 10.1038/onc.2015.154.


Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition.

Pellecchia A, Pescucci C, De Lorenzo E, Luceri C, Passaro N, Sica M Oncogenesis. 2013; 1:e20.

PMID: 23552736 PMC: 3412649. DOI: 10.1038/oncsis.2012.20.